Voyager Therapeutics, Inc.
HealthcareNASDAQ:VYGR · NASDAQ Global Select
+$0.04 today
Vol 0.54M · Avg 0.59M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+6.06%
Period High
$5.33
Period Low
$2.94
Latest
$3.50
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$566.68M
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$463.35M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$359.32M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$353.00M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$276.28M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$250.78M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$211.13M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$198.11M
Humacyte, Inc.
NASDAQ:HUMA
$177.24M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$111.51M
What is the latest VYGR filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does VYGR have?
Intrinsic Alpha currently shows 20 recent filings for VYGR.
Explore More
Continue the stock analysis
Jump to another research area for this company.